parkinson glutathione oxidative ipsc crispr Induced Pluripotent Stem Cells Derived Cellular Models for Investigating Parkinson's Disease Pathogenesis and Drug Screening | Stem Cell Reviews and Reports Non-invasive CRISPR/Cas9 nanocapsules specifically edit
Non invasive CRISPR Cas9 nanocapsules specifically edit synuclein for effective Parkinson's disease treatment ScienceDirect Modelling Parkinson's Disease: iPSCs towards Better Understanding of Human Pathology Alpha synuclein determines ferroptosis sensitivity in dopaminergic neurons via modulation of ether phospholipid membrane composition: Cell Reports The Mitochondrial Interactome in Parkinson's and Huntington's Diseases Nature Cell and Science Genome wide CRISPRi a screens in human neurons link lysosomal failure to ferroptosis bioRxiv
Pay in 4 interest-free payments of $7.29 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7




